Daniel Gomez, MD. ENDOOLAP
Introduction: Obesity is a worlwide epidemic associated to multiple comorbidities. Diet and exercise are poorly effective with not long term results.
Bariatric surgical procedures are effective but still associated to major complications however with a low mortality rate.
There is a need for less invasive weight loss procedures and devices such as endoscopic weight loss balloon as an alternative for patients non candidates to bariatric surgery.
Methods: We present a 3 years experience of endoscopic intragastric balloon placement (ORBERA, Apollo Endosurgery, Inc) performed in a total of 89 patients and done in an ambulatory endoscopy unit.
Median follow up of 30 months
Removal at 6 months
Short term weight loss range 12 to 26 kg
Weight loss sustained at 12 months 48 %
20 % of patients fail to achieve significance weight loss
No major complications presented in this series
Conclusions: The endoscopic intragastric balloon is thought to induced early satiety by partially filling the stomach; as presented in this case series results, this is a promising alternative of weight loss in a growing public health problem.
Long term data on the safety, efficacy and durability of endoluminal bariatric procedures are needed.
Presented at the SAGES 2017 Annual Meeting in Houston, TX.
Abstract ID: 80707
Program Number: P509
Presentation Session: Poster (Non CME)
Presentation Type: Poster